December 22, 2022
Life Sciences
  • Roche Holding AG said the FDA approved Actemra, its monoclonal antibody for treating COVID-19 in hospitalized adults. The agency’s decision comes weeks after it revoked the emergency use authorization for Eli Lilly & Co.’s monoclonal antibody treatment, bebtelovimab, because it was ineffective against new omicron subvariants. (Article here)